|
Dec 14
|
UPDATE 2-US CDC says there's urgent need to increase respiratory vaccine coverage
|
|
Dec 14
|
Moderna: Stock soars on cancer vaccine data, CEO Bancel takes on commercial role
|
|
Dec 14
|
Several Reasons for the Outperformance of GSK plc (GSK) in Q3
|
|
Dec 12
|
30 Largest Pharmaceutical Companies in the World
|
|
Dec 12
|
19 Countries that Encourage Immigration from USA
|
|
Dec 12
|
GSK Awards $1M in COiMMUNITY Initiative Grants to Support Adult Immunization and Health Equity
|
|
Dec 7
|
FTC warns pharma companies on excessive drug patenting
|
|
Dec 7
|
20 Countries with Free Health Care
|
|
Dec 4
|
Glaxo (GSK) Upgraded to Buy: What Does It Mean for the Stock?
|
|
Dec 4
|
Is GSK PLC Sponsored ADR (GSK) Stock Outpacing Its Medical Peers This Year?
|
|
Dec 2
|
Boasting A 52% Return On Equity, Is GSK plc (LON:GSK) A Top Quality Stock?
|
|
Nov 27
|
GSK Key Drugs & Vaccines Help Stock Outperform Industry YTD
|
|
Nov 27
|
3 Great Foreign Companies to Invest in Right Now
|
|
Nov 26
|
15 Best Drug Stocks To Invest In
|
|
Oct 27
|
Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
|
|
Oct 25
|
GSK (GSK) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Oct 25
|
New Data for AREXVY, GSK’s RSV Vaccine, Show Potential to Help Protect Adults Aged 50 to 59 at Increased Risk for RSV Disease
|
|
Aug 29
|
Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations
|
|
Aug 26
|
3 Growth Stocks to Ride the Coming Bull Market in Style
|
|
Aug 26
|
Ken Fisher’s Top 15 Healthcare Stock Picks
|